Related Experiment Videos
[Gemfibrozil-induced myopathy]
Harefuah
|November 1, 1993
Summary
Gemfibrozil, a lipid-lowering drug, can cause myopathy, a muscle disorder. This risk is higher in patients with chronic renal failure, highlighting the need for careful monitoring.
Area of Science:
- Pharmacology
- Nephrology
- Cardiology
Background:
- Hyperlipidemia and diabetes mellitus are common comorbidities.
- Chronic renal failure increases the risk of drug-induced complications.
- Gemfibrozil is a lipid-lowering agent with known potential side effects.